CN1304752A - Clematis capsule and its preparing process - Google Patents

Clematis capsule and its preparing process Download PDF

Info

Publication number
CN1304752A
CN1304752A CN 00131191 CN00131191A CN1304752A CN 1304752 A CN1304752 A CN 1304752A CN 00131191 CN00131191 CN 00131191 CN 00131191 A CN00131191 A CN 00131191A CN 1304752 A CN1304752 A CN 1304752A
Authority
CN
China
Prior art keywords
radix
capsule
standby
caulis
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 00131191
Other languages
Chinese (zh)
Inventor
张志祥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 00131191 priority Critical patent/CN1304752A/en
Publication of CN1304752A publication Critical patent/CN1304752A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A Chinese-medicine in the form of capsule for treating rheumatic and rheumatoid arthritis is prepared from 33 Chinese-medicinal materials including clematis root, astragalus root, spatholobus stem, giant knotweed rhizome, etc. Its advantages include high curative effect up to 90% or higher and no toxic by-effect.

Description

Clematis capsule and preparation method thereof
The present invention relates to a kind of medicine that cures mainly various rheumatism, rheumatoid arthritis and preparation method thereof.
Existing Chinese patent medicine FENGSHI GUTONG JIAONANG, mainly be to be used for the treatment of extremity, lumbar vertebrae pain, rheumatic arthritis disease person due to the arthralgia due to cold-dampness by dispelling cold by warming the meridian, removing obstruction in the collateral to relieve pain, rather than wet based on promoting blood circulation by removing wind, pay attention to strengthening the body resistance and reach the purpose of curing the disease.
The object of the present invention is to provide a kind of promoting blood circulation by removing wind, eliminating dampness and dredging channels, strengthening the body resistance, relieving spasm to stop pain is used for the treatment of clematis capsule of rheumatism, rheumatoid patient and preparation method thereof.
Technical scheme of the present invention is: a kind of clematis capsule is characterized in that its prescription is (weight in grams):
Radix Astragali 10-25 Caulis seu Radix Schisandrae Henryi 8-30 Rhizoma Polygoni Cuspidati 10-24 Radix seu Caulis fici Martinii 5-15 Herba Siegesbeckiae 40-50 Caulis Akebiae 1-5
The parasitic 2-7 of Radix Aristolochiae yunnanensis 1-5 Radix Uncariae rhynchophyllae 1-4 Cortex Phellodendri 1-5 Radix Glycyrrhizae 1-4 Radix Stephaniae Tetrandrae 8-15
Ramulus Cinnamomi 1-5 Caulis et folium stauntoniae 1-6 prestige is recorded celestial 20-40 Olibanum 1-6 Myrrha 1-3 Stigma Croci 1
Rhizoma Pinelliae Preparatum 1-3 Radix Angelicae Sinensis 2-8 Rhizoma Gastrodiae 1-5 Solenognathus 0.5-3 Hippocampus 0.5-3 Rhizoma Atractylodis 2-8
Scorpio 0.5-2 Scolopendra 0.1-2 Agkistrodon 0.1-2 Formica fusca 1-5 Radix Aristolochiae 2-8 Radix Notoginseng 1-5
Arisaema Cum Bile 1-5 Radix Panacis Quinquefolii 10-20 Cordyceps 1-5
Its preparation method is:
A. will adding medicine to, it is qualified to concoct, and weighing is assorted standby;
B. extract the evaporation and concentration part:
1. preceding 17 flavors (Radix Astragali is to Myrrha) are dropped in the extraction pot, fry in shallow oil and carry;
2. extracting solution is put and concentrated clear paste in the membrane evaporator;
3. clear paste is put and tempered in the reaction pot that to be condensed into old cream standby;
C. drying, pulverizing, screened part:
With Rhizoma Pinelliae Preparatum dry levigation of 16 flavor medicines (wherein Agkistrodon, big bar, parch) to the Cordyceps, cross 80 mesh sieves, mix homogeneously is standby;
D. granulate: old cream that will " b " and " the fine powder adding stirring of c, granulation, drying, sterilization, granulate are standby;
E. encapsulated: with pack into No. 1 capsule (0.3/) polishing of above dried granule;
F. exterior and interior packing: capsule is put on the 250 model blister packaging machine row bubble-cap plastic-aluminum packaging by hot pressing or pack in the carton box bubble cap tray into every box 2 plates, promptly 0.3/ * 12/plate * 2 plates/box.
The present invention compares with existing similar Chinese patent medicine, except that having except that the Joint effect of rheumatism, also has following characteristics:
1, based on the wet pain relieving of promoting blood circulation by removing wind, pay attention to strengthening the body resistance simultaneously, more with the aged because of the patient who suffers from lumbago and skelalgia, how empty body is, eliminating evil so answer strengthening the body resistance;
2, pay attention to treating both the principal and secondary aspects of a disease simultaneously at the wind-damp dispelling analgesic, with the kidney invigorating, hemopoietics such as parasitism, Radix Angelicae Sinensis, invigorate blood circulation, make its better efficacy, increase eliminating evil ability;
3, with Radix Clematidis except that wind-damp dispelling, also have the effect of removing obstruction in the collateral to relieve pain preferably;
4, by clinical UR for many years, old lumbago and skelalgia and various rheumatism are had better curative effect, effective percentage can reach more than 90%, does not see untoward reaction and toxic and side effects.
The invention will be further described below in conjunction with embodiment.
Selected above-mentioned prescription composition 1000 grams, wherein: Radix Clematidis 10%, the Radix Astragali 10%, Caulis seu Radix Schisandrae Henryi 10%, Rhizoma Polygoni Cuspidati 10%, Radix seu Caulis fici Martinii 5% Herba Siegesbeckiae 21%, Caulis Akebiae 1%, Radix Aristolochiae yunnanensis 1.4%, Radix Uncariae rhynchophyllae 1%, Cortex Phellodendri 1%, Radix Glycyrrhizae 1%, Radix Stephaniae Tetrandrae 5%, parasitic 2.4%, Ramulus Cinnamomi 1%, Caulis et folium stauntoniae 1.4%, Olibanum 0.5%, Myrrha 0.5%, Stigma Croci 0.7%, Rhizoma Pinelliae Preparatum 1%, Radix Angelicae Sinensis 1.4%, Rhizoma Gastrodiae 1%, Solenognathus 0.2%, Hippocampus 0.2%, Rhizoma Atractylodis 2.4%, Scorpio 0.2%, Scolopendra 0.1%, Agkistrodon 0.1%, Formica fusca 1%, Radix Aristolochiae 2.4%, Radix Notoginseng 1%, Arisaema Cum Bile 1%, Radix Panacis Quinquefolii 6.7%, Cordyceps 1%.Above component is promptly got medicine of the present invention by the preparation of the preparation method in the technique scheme.
Medicine of the present invention is paid attention to strengthening the body resistance especially when dispeling wind, cold, wet, heat, exopathogen, both treated disease, strengthens autoimmune function simultaneously, makes health encroached on by exopathogen; Take medicine of the present invention and at first feel body warmer, then pain relief fades away, fully recovers.See through accepting rheumatoid arthritis people 42 examples for medical treatment, clinical manifestation all has 3 or 3 above arthroncuss, pain, morning deadlock, limitation of activity and inflammation performance, year surplus course of disease elder reaches ten, weak point person then three, four months, 80% above case is looked into the rheumatoid factor positive, erythrocyte sedimentation rate raises in various degree, be in hospital and do not wait in 20-120 days, all patient all takes medicine of the present invention, symptom begins to improve after treating a week, the check erythrocyte sedimentation rate all has decline behind the two weeks, the rheumatoid factor clearance time roughly after one month, total effective rate 90.5%.

Claims (2)

1, a kind of clematis capsule is characterized in that its prescription is (weight in grams):
Radix Astragali 10-25 Caulis seu Radix Schisandrae Henryi 8-30 Rhizoma Polygoni Cuspidati 10-24 Radix seu Caulis fici Martinii 5-15 Herba Siegesbeckiae 40-50 Caulis Akebiae 1-5
The parasitic 2-7 of Radix Aristolochiae yunnanensis 1-5 Radix Uncariae rhynchophyllae 1-4 Cortex Phellodendri 1-5 Radix Glycyrrhizae 1-4 Radix Stephaniae Tetrandrae 8-15
Ramulus Cinnamomi 1-5 Caulis et folium stauntoniae 1-6 prestige is recorded celestial 20-40 Olibanum 1-6 Myrrha 1-3 Stigma Croci 1-4
Rhizoma Pinelliae Preparatum 1-3 Radix Angelicae Sinensis 2-8 Rhizoma Gastrodiae 1-5 Solenognathus 0.5-3 Hippocampus 0.5-3 Rhizoma Atractylodis 2-8
Scorpio 0.5-2 Scolopendra 0.1-2 Agkistrodon 0.1-2 Formica fusca 1-5 Radix Aristolochiae 2-8 Radix Notoginseng 1-5
Arisaema Cum Bile 1-5 Radix Panacis Quinquefolii 10-20 Cordyceps 1-5
2, a kind of clematis capsule is characterized in that its preparation method is:
A. will adding medicine to, it is qualified to concoct, and weighing is assorted standby;
B. extract the evaporation and concentration part:
1. preceding 17 flavors (Radix Astragali is to Myrrha) are dropped in the extraction pot, fry in shallow oil and carry;
2. extracting solution is put and concentrated clear paste in the membrane evaporator;
3. clear paste is put and tempered in the reaction pot that to be condensed into old cream standby;
C. drying, pulverizing, screened part:
With Rhizoma Pinelliae Preparatum dry levigation of 16 flavor medicines (wherein Agkistrodon, big bar, parch) to the Cordyceps, cross 80 mesh sieves, mix homogeneously is standby;
D. granulate: the old cream of " b " is standby with fine powder adding stirring, granulation, drying, sterilization, the granulate of " c ";
E. encapsulated: with pack into No. 1 capsule (0.3/) polishing of above dried granule;
F. exterior and interior packing: capsule is put on the 250 model blister packaging machine row bubble-cap plastic-aluminum packaging by hot pressing or pack in the carton box bubble cap tray into every box 2 plates, promptly 0.3/ * 12/plate * 2 plates/box.
CN 00131191 2000-12-01 2000-12-01 Clematis capsule and its preparing process Pending CN1304752A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 00131191 CN1304752A (en) 2000-12-01 2000-12-01 Clematis capsule and its preparing process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 00131191 CN1304752A (en) 2000-12-01 2000-12-01 Clematis capsule and its preparing process

Publications (1)

Publication Number Publication Date
CN1304752A true CN1304752A (en) 2001-07-25

Family

ID=4594539

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 00131191 Pending CN1304752A (en) 2000-12-01 2000-12-01 Clematis capsule and its preparing process

Country Status (1)

Country Link
CN (1) CN1304752A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100400057C (en) * 2005-09-19 2008-07-09 蓝子花 Xunmagen medicated liquor
CN102641447A (en) * 2012-05-09 2012-08-22 荣成市商贸城卫生所 Traditional Chinese medicine composition for treating rheumatoid arthritis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100400057C (en) * 2005-09-19 2008-07-09 蓝子花 Xunmagen medicated liquor
CN102641447A (en) * 2012-05-09 2012-08-22 荣成市商贸城卫生所 Traditional Chinese medicine composition for treating rheumatoid arthritis
CN102641447B (en) * 2012-05-09 2014-06-04 于晓棠 Traditional Chinese medicine composition for treating rheumatoid arthritis

Similar Documents

Publication Publication Date Title
CN101987123B (en) Medicament for easing pain of human body and preparation method thereof
CN101987122B (en) Medicament for easing pain of human body and preparation method thereof
CN1224614A (en) Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation
CN1031186A (en) The prescription and the facture of specially good effect bony spur antiphlogistine
CN1204523A (en) Prescription of dispelling wind and strengthening bone wine and preparation method
CN1899535A (en) Method for preparing dermopathic blood toxic capsule
CN101874892A (en) Health-care external liquid medicine for treating bone hyperplasia and lumbar disc hernia
CN102258714B (en) Chinese medicinal capsules for treating hypertension
CN1824009A (en) Multipurpose medicinal composition capable of oral administration and external use
CN1263503C (en) 'Changyuan' capsule and preparing techniue
CN1304752A (en) Clematis capsule and its preparing process
CN1077896A (en) Medicine for psoriasis and manufacture method
CN100411666C (en) Broad-specturm medicine for treating snake venom poisoning
CN1223122A (en) Medicine for curing cerebrovascular and cardiovascular diseases and preparation process thereof
CN1186056C (en) medicine for treating hyperosteogeny
CN1772227A (en) Chinese medicine prepn with body balance essence and its prepn process
CN1057912C (en) "Danshenye" Chinese medicinal liquid for treatment of cholecystitis
CN1059120C (en) Chinese medicine for treating bone wound
CN1201773C (en) Fresh air oil and production process thereof
CN1322558A (en) Liver cancer resisting medicine
CN1377659A (en) Rash-eliminating and psoriasis-treating medicine liquid
CN1058622C (en) Rehabilitation powder for hepatitis B
CN1181859C (en) Capsule for protrusion of vertebral disc and its preparation
CN1973880A (en) Externally applied medicine for treating gouty arthritis and its prepn
CN1173365A (en) Chinese medicinal preparation for curing rheumatism and rheumatoid disease and its prepn. method

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication